NCT02075281View on ClinicalTrials.gov

Effect of LAPS-Exendin on Body Weight in Obese Population

PHASE2CompletedINTERVENTIONAL
Enrollment

297

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

February 28, 2015

Conditions
Obesity
Interventions
BIOLOGICAL

HM11260C

Glucagon-like peptide-1 analogue

BIOLOGICAL

Placebo

Trial Locations (1)

Unknown

Hanmi pharmaceutical, Los Angeles

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT02075281 - Effect of LAPS-Exendin on Body Weight in Obese Population | Biotech Hunter | Biotech Hunter